How GLP-1 Drugs Made the Gym Industry Richer, Not Poorer
The Wall Street thesis that Ozempic would empty gyms collapsed in plain sight. Here is what the 2025 filings actually show. The 60-second version In late 2023, gym stocks dropped on a Wall Street thesis that GLP-1 weight-loss drugs like Ozempic, Wegovy, and Mounjaro would empty fitness facilities. The thesis was that thin people do … Read more